ModivCare Inc. (NASDAQ:MODV – Get Free Report) major shareholder Q Global Capital Management, L bought 50,748 shares of the business’s stock in a transaction that occurred on Wednesday, October 23rd. The stock was acquired at an average cost of $14.16 per share, for a total transaction of $718,591.68. Following the completion of the purchase, the insider now directly owns 1,475,038 shares of the company’s stock, valued at $20,886,538.08. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
ModivCare Stock Performance
Shares of MODV stock opened at $14.41 on Friday. ModivCare Inc. has a 12 month low of $11.00 and a 12 month high of $52.33. The stock has a market cap of $204.78 million, a PE ratio of -0.92, a price-to-earnings-growth ratio of 1.82 and a beta of 0.49. The company’s fifty day moving average price is $19.67 and its 200-day moving average price is $23.16. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 103.63.
ModivCare (NASDAQ:MODV – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.77 by ($0.80). ModivCare had a negative net margin of 5.80% and a positive return on equity of 27.52%. The company had revenue of $698.30 million for the quarter, compared to the consensus estimate of $701.00 million. During the same period last year, the business earned $1.41 EPS. The firm’s quarterly revenue was down .1% on a year-over-year basis. On average, equities analysts expect that ModivCare Inc. will post 1.06 EPS for the current fiscal year.
Hedge Funds Weigh In On ModivCare
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on MODV shares. Barrington Research lifted their price objective on ModivCare from $19.00 to $22.00 and gave the stock an “outperform” rating in a research report on Thursday, October 3rd. Lake Street Capital cut their price target on shares of ModivCare from $50.00 to $30.00 and set a “buy” rating on the stock in a report on Tuesday, September 17th. Finally, Jefferies Financial Group decreased their price objective on shares of ModivCare from $25.00 to $14.00 and set a “hold” rating for the company in a report on Friday, September 13th.
Check Out Our Latest Report on ModivCare
ModivCare Company Profile
ModivCare Inc, a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other.
Read More
- Five stocks we like better than ModivCare
- What Do S&P 500 Stocks Tell Investors About the Market?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Using the MarketBeat Dividend Yield Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for ModivCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ModivCare and related companies with MarketBeat.com's FREE daily email newsletter.